Clorox Q3 2024 Adj EPS $1.71 Beats $1.37 Estimate, Sales $1.81B Miss $1.87B Estimate
Portfolio Pulse from Benzinga Newsdesk
Clorox reported Q3 2024 adjusted EPS of $1.71, surpassing the $1.37 estimate, but its sales of $1.81B fell short of the $1.87B forecast, marking a 5.48% decrease from the previous year.
April 30, 2024 | 8:12 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Clorox's Q3 2024 earnings surpassed expectations with an EPS of $1.71 against a $1.37 estimate, but sales missed forecasts at $1.81B versus $1.87B expected.
While Clorox's EPS beat may positively impact investor sentiment due to better-than-expected profitability, the sales miss and year-over-year decline could temper enthusiasm, suggesting a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100